Merial Acquires Vaccine Manufacturer Newport Labs



Published:

Animal health company Merial has acquired biologics manufacturer Newport Laboratories of Worthington, Minn., Merial reported today.

Newport Laboratories uses molecular diagnostic technology to identify pathogens and produces autogenous vaccines with a focus on swine and bovine production markets, according to Duluth, Ga.-based Merial, a subsidiary of Paris-based Sanofi.

“Newport has demonstrated over time the ability to screen field samples and produce autogenous vaccines from large integrated producers with remarkable efficiency,” said Jose Barella, CEO of Merial. “The combination of Newport’s expertise and Merial’s strength in technology and geographic footprint will reinforce our exposure to the swine market segment and illustrates our strategy to expand our position in treatments for production animals.”

Autogenous vaccines are developed and produced from a virus or bacteria strain that has been isolated from the tissue samples submitted from a particular farm, according to Newport Laboratories, which in 2010 launched its first commercial swine vaccine for Haemophilus parasuis called ParaSail.

Newport Laboratories will continue to operate from its Worthington offices.

<HOME>

Edit Module
Edit ModuleShow Tags

Archive »Read More

UT Helps Get Steer Back on His Feet

Dudley lost a foot in a farm accident but gained an appendage courtesy of the University of Tennessee and others.

Reminder: Keep Chocolate Away From Dogs

More than half of U.K. veterinarians treated cases of chocolate poisoning last Easter.

Canine Cancer Lab TVAX Gets $2 Million

TVAX Animal Health has a large bankroll to draw from for its research into cancer immunotherapy.

Add your comment:
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module